Genentech Inc - Strategic SWOT Analysis Review

Genentech Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy –  summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Genentech Inc (Genentech), a subsidiary of F. Hoffmann-La Roche Ltd, is a biotechnology company that discovers, develops, manufactures and commercializes medicines to address serious medical needs. It offers drugs in various therapeutic areas including oncology, immunology, ophthalmology, metabolism, neurology and infectious disease, among others. Its pipeline products include Emicizumab (RG6013, ACE910), a bispecific monoclonal antibody used to replace the function of protein in the blood clotting process; and Entrectinib (RXDX-101, RG6268), a CNS-active tyrosine-kinase inhibitor intended for the treatment of non-small cell lung cancer; among others. The company has partnership with BioLineRx, Charles River Laboratories International and Amunix, among others. Genentech is headquartered in South San Francisco, California, the US.

Genentech Inc Key Recent Developments

Mar 04,2020: Pulmonary Fibrosis Foundation launches industry consortium to identify biomarkers in Pulmonary Fibrosis
Feb 28,2020: FinnGen grows to one of the largest private-public studies in the world
Feb 26,2020: Bicycle Therapeutics, Genentech sign $1.7bn cancer therapies deal
Feb 21,2020: Leaders from 24 companies in the US Pharmaceutical Supply Chain collaborate to submit the MediLedger DSCSA Pilot Project Final Report to the FDA, proposing blockchain for an interoperable track and trace system for US prescription drugs
Feb 11,2020: Lilly and Genentech announce two failures in Alzheimer’s disease prevention study

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with  detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.
 


Section 1 - About the Company
Genentech Inc - Key Facts
Genentech Inc - Key Employees
Genentech Inc - Key Employee Biographies
Genentech Inc - Major Products and Services
Genentech Inc - History
Genentech Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Genentech Inc - Business Description
Genentech Inc - SWOT Analysis
SWOT Analysis - Overview
Genentech Inc - Strengths
Genentech Inc - Weaknesses
Genentech Inc - Opportunities
Genentech Inc - Threats
Genentech Inc - Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Genentech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Genentech Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Genentech Inc, Recent Deals Summary
Section 4 – Company’s Recent Developments
Mar 04, 2020: Pulmonary Fibrosis Foundation launches industry consortium to identify biomarkers in Pulmonary Fibrosis
Feb 28, 2020: FinnGen grows to one of the largest private-public studies in the world
Feb 26, 2020: Bicycle Therapeutics, Genentech sign $1.7bn cancer therapies deal
Feb 21, 2020: Leaders from 24 companies in the US Pharmaceutical Supply Chain collaborate to submit the MediLedger DSCSA Pilot Project Final Report to the FDA, proposing blockchain for an interoperable track and trace system for US prescription drugs
Feb 11, 2020: Lilly and Genentech announce two failures in Alzheimer’s disease prevention study
Nov 06, 2019: Genentech, makers of new Flu treatment, Xofluza (baloxavir marboxil), announces partnership with virtual health platform, Plushcare
Oct 09, 2019: ICER finds lack of evidence to support blockbuster drug price hikes
Oct 09, 2019: Sosei Heptares to receive US$3 Million Payment from Genentech on nomination of a new GPCR Disease Target
Sep 18, 2019: SU2C to support clinical trials in breast and prostate cancers
Sep 06, 2019: JHL reaches settlement agreement with Roche/Genentech
Section 5 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
 


List Of Tables


Genentech Inc, Key Facts
Genentech Inc, Key Employees
Genentech Inc, Key Employee Biographies
Genentech Inc, Major Products and Services
Genentech Inc, History
Genentech Inc, Other Locations
Genentech Inc, Key Competitors
Genentech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Genentech Inc, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Genentech Inc, Recent Deals Summary
 


List Of Figures


Genentech Inc, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Genentech Inc, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020
 


Genentech USA Inc - Strategic SWOT Analysis Review

Genentech USA Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the companys history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information

USD 125 View Report

Binx Health Inc - Product Pipeline Analysis, 2021 Update

Binx Health Inc (Binx Health), a subsidiary of Binx Health Ltd, is a provider of near-patient and point of care (POC) testing solutions for womens health. The company develops its

USD 750 View Report

Profound Medical Inc - Product Pipeline Analysis, 2021 Update

Profound Medical Inc (Profound Medical) is a medical device company that develops and markets solutions to deliver precise ablation of prostate. Its proprietary technology, TULSA-PRO, by combining real-time magnetic resonance

USD 750 View Report

Fill The Form For Sample Request

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available